Andexanet alfa vs 4-factor prothrombin complex concentrate for intracranial hemorrhage at a level I trauma hospital

被引：0
|
作者：
Considine, Kelly [1 ]
Fuchs, Ryan [2 ]
Severt, Anthony [1 ]
Driver, Brian [1 ]
Gorlin, Jed [1 ]
Hodson, Lisa [1 ]
Cole, Jon [2 ]
机构：
[1] Hennepin Healthcare, Minneapolis, MN USA
[2] Minnesota Poison Control Syst, Minneapolis, MN USA
来源：
CLINICAL TOXICOLOGY | 2022年 / 60卷
关键词：
Andexanet alfa; 4-factor prothrombin complex concentrate; factor X inhibitors;
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
67
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] The use of andexanet alfa and 4-factor prothrombin complex concentrate in intracranial hemorrhage
    Oh, Elly S.
    Schulze, Paul
    Diaz, Frank
    Shah, Kunal
    Rios, Jose
    Silverman, Michael E.
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 64 : 74 - 77
  • [2] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    [J]. NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [3] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    [J]. Neurocritical Care, 2021, 35 : 255 - 261
  • [4] Comparison of 4-factor prothrombin complex concentrate and andexanet alfa for reversal of apixaban and rivaroxaban in the setting of intracranial hemorrhage
    Michelle Lipski
    Stacy Pasciolla
    Kevin Wojcik
    Brian Jankowitz
    Lauren A. Igneri
    [J]. Journal of Thrombosis and Thrombolysis, 2023, 55 : 519 - 526
  • [5] Comparison of 4-factor prothrombin complex concentrate and andexanet alfa for reversal of apixaban and rivaroxaban in the setting of intracranial hemorrhage
    Lipski, Michelle
    Pasciolla, Stacy
    Wojcik, Kevin
    Jankowitz, Brian
    Igneri, Lauren A.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (03) : 519 - 526
  • [6] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Troyer, Camille
    Nguyen, Wesley
    Xie, Annie
    Wimer, Dexter
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (01) : 149 - 155
  • [7] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Camille Troyer
    Wesley Nguyen
    Annie Xie
    Dexter Wimer
    [J]. Journal of Thrombosis and Thrombolysis, 2023, 55 : 149 - 155
  • [8] The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage
    Irizarry-Gatell, Vivian M.
    Bacchus, Michael W.
    De Leo, Edward K.
    Zhang, Yang
    Lagasse, Carrie A.
    Khanna, Anna Y.
    Harris, Neil S.
    Zumberg, Marc S.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (03) : 94 - 100
  • [9] Traumatic intracranial hemorrhage in the setting of 4-factor prothrombin complex concentrate
    Mushlin, Harry
    Mushlin, Harry
    Cunnion, Mary
    Hines, Michele
    Kufera, Joseph
    Pajoumand, Mehrnaz
    Aarabi, Bizhan
    Stein, Deborah
    [J]. JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 55 - 56
  • [10] Andexanet Alfa Is Associated With Reduced In-hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate Among Patients With Intracranial or Gastrointestinal Bleeding
    Fermann, G.
    Dobesh, P.
    Danese, M.
    Lovelace, B.
    Christoph-Schubel, M.
    Dettling, T.
    Koch, B.
    Coleman, C.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2022, 80 (04) : S29 - S29
12345